Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis

Paul J Hengeveld; Hendrik Veelken; Cornelis A M van Bergen; Edwin Quinten; Mischa Y L Vervoordeldonk; Wahija Ismailzada; Rob S Barendse; Julie M N Dubois; Marinus H J van Oers; Christian H Geisler; Arnon P Kater; Peter E Westerweel; Anton W Langerak; Mark-David Levin

doi:10.1038/s41375-023-01975-0

Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis

Paul J Hengeveld, Hendrik Veelken, Cornelis A M van Bergen, Edwin Quinten, Mischa Y L Vervoordeldonk, Wahija Ismailzada, Rob S Barendse, Julie M N Dubois, Marinus H J van Oers, Christian H Geisler, Arnon P Kater, Peter E Westerweel, Anton W Langerak, Mark-David Levin^*

^*Corresponding author af dette arbejde

Afdeling for Blodsygdomme

Originalsprog	Engelsk
Tidsskrift	Leukemia
Vol/bind	37
Udgave nummer	9
Sider (fra-til)	1929-1932
Antal sider	4
ISSN	0887-6924
DOI	https://doi.org/10.1038/s41375-023-01975-0
Status	Udgivet - sep. 2023

Adgang til dokumentet

10.1038/s41375-023-01975-0

Andre filer og links

Link to publication in Scopus

Citationsformater

Hengeveld, P. J., Veelken, H., van Bergen, C. A. M., Quinten, E., Vervoordeldonk, M. Y. L., Ismailzada, W., Barendse, R. S., Dubois, J. M. N., van Oers, M. H. J., Geisler, C. H., Kater, A. P., Westerweel, P. E., Langerak, A. W., & Levin, M.-D. (2023). Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis. Leukemia, 37(9), 1929-1932. https://doi.org/10.1038/s41375-023-01975-0

Hengeveld, PJ, Veelken, H, van Bergen, CAM, Quinten, E, Vervoordeldonk, MYL, Ismailzada, W, Barendse, RS, Dubois, JMN, van Oers, MHJ, Geisler, CH, Kater, AP, Westerweel, PE, Langerak, AW & Levin, M-D 2023, 'Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis', Leukemia, bind 37, nr. 9, s. 1929-1932. https://doi.org/10.1038/s41375-023-01975-0

@article{33c38eb08862456794a0e4453ab87472,

title = "Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis",

keywords = "Humans, Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy, Prognosis",

author = "Hengeveld, {Paul J} and Hendrik Veelken and {van Bergen}, {Cornelis A M} and Edwin Quinten and Vervoordeldonk, {Mischa Y L} and Wahija Ismailzada and Barendse, {Rob S} and Dubois, {Julie M N} and {van Oers}, {Marinus H J} and Geisler, {Christian H} and Kater, {Arnon P} and Westerweel, {Peter E} and Langerak, {Anton W} and Mark-David Levin",

year = "2023",

month = sep,

doi = "10.1038/s41375-023-01975-0",

language = "English",

volume = "37",

pages = "1929--1932",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis

AU - Hengeveld, Paul J

AU - Veelken, Hendrik

AU - van Bergen, Cornelis A M

AU - Quinten, Edwin

AU - Vervoordeldonk, Mischa Y L

AU - Ismailzada, Wahija

AU - Barendse, Rob S

AU - Dubois, Julie M N

AU - van Oers, Marinus H J

AU - Geisler, Christian H

AU - Kater, Arnon P

AU - Westerweel, Peter E

AU - Langerak, Anton W

AU - Levin, Mark-David

PY - 2023/9

Y1 - 2023/9

KW - Humans

KW - Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=85165293126&partnerID=8YFLogxK

U2 - 10.1038/s41375-023-01975-0

DO - 10.1038/s41375-023-01975-0

M3 - Letter

C2 - 37479761

SN - 0887-6924

VL - 37

SP - 1929

EP - 1932

JO - Leukemia

JF - Leukemia

IS - 9

ER -